معرفی
Meghan Morean is a Research Scientist in the Department of Psychiatry at Yale School of Medicine, Yale University. Her research focuses on factors influencing initiation, maintenance, and cessation of substance use (e.g., nicotine, alcohol, cannabis), with expertise in electronic nicotine delivery systems (ENDS), smoking cessation, and survey methodology. She leads studies on adolescent and adult ENDS use, including flavor preferences, device modifications, and health outcomes.
Education: PhD in Psychology from Yale University (2011); ScB in Psychology from Brown University (2004). She collaborates with institutions like the Yale Tobacco Center of Regulatory Science (funded by a $20M federal grant) and the Tobacco Research in Youth (TRY) group.
Research interests emphasize public health implications of vaping trends, including LGBTQ-targeted marketing, dual nicotine/cannabis use, and flavor regulation. Her work bridges epidemiology and behavioral science, addressing gaps in understanding adolescent and young adult substance use behaviors.
Key contributions include developing validated assessment tools (e.g., Self-Report Habit Index) and evaluating vaping cessation strategies. Her interdisciplinary approach integrates clinical, social, and policy perspectives to inform public health interventions.